Update on current research into haploidentical hematopoietic stem cell transplantation

被引:21
作者
Sun, Yu-Qian [1 ,2 ]
Chang, Ying-Jun [1 ,2 ]
Huang, Xiao-Jun [1 ,2 ,3 ]
机构
[1] Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China
[2] Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China
[3] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Baltimore protocol; Beijing protocol; graft-versus-host disease; haploidentical stem cell transplantation; poor graft function; relapse; severe aplastic anemia; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; ACUTE MYELOID-LEUKEMIA; SEVERE APLASTIC-ANEMIA; REGULATORY T-CELLS; DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; UNRELATED DONOR TRANSPLANTATION; COLONY-STIMULATING FACTOR; UMBILICAL-CORD BLOOD;
D O I
10.1080/17474086.2018.1447379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Haploidentical stem cell transplantation (Haplo-SCT) is currently a suitable alternative worldwide for patients with hematological diseases, who lack human leukocyte antigen (HLA)-matched siblings or unrelated donors.Areas covered: This review summarizes the advancements in Haplo-SCT in recent years, primarily focusing on the global trends of haploidentical allograft, the comparison of outcomes between Haplo-SCT and other transplantation modalities, strategies for improving clinical outcomes, including donor selection, hematopoietic reconstitution promotion, and graft-versus-host disease, and relapse prevention/management, as well as the expanded indications of Haplo-SCT, such as severe aplastic anemia, myeloma and lymphoma.Expert commentary: Haploidentical allografts, including granulocyte colony-stimulating factor-based protocol and a post-transplant cyclophosphamide-based protocol, have been the mainstream strategy for Haplo-SCT. However, there are many unanswered questions in this field.
引用
收藏
页码:273 / 284
页数:12
相关论文
共 139 条
[31]   Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets [J].
Chang, Ying-Jun ;
Zhao, Xiang-Yu ;
Xu, Lan-Ping ;
Zhang, Xiao-Hui ;
Wang, Yu ;
Han, Wei ;
Chen, Huan ;
Wang, Feng-Rong ;
Mo, Xiao-Dong ;
Zhang, Yuan-Yuan ;
Huo, Ming-Rui ;
Zhao, Xiao-Su ;
Kong, Y. ;
Liu, Kai-Yan ;
Huang, Xiao-Jun .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
[32]   Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].
Chen, Robert ;
Zinzani, Pier Luigi ;
Fanale, Michelle A. ;
Armand, Philippe ;
Johnson, Nathalie A. ;
Brice, Pauline ;
Radford, John ;
Ribrag, Vincent ;
Molin, Daniel ;
Vassilakopoulos, Theodoros P. ;
Tomita, Akihiro ;
von Tresckow, Bastian ;
Shipp, Margaret A. ;
Zhang, Yinghua ;
Ricart, Alejandro D. ;
Balakumaran, Arun ;
Moskowitz, Craig H. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+
[33]   Haploidentical transplantation in patients with acquired aplastic anemia [J].
Ciceri, F. ;
Lupo-Stanghellini, M. T. ;
Korthof, E. T. .
BONE MARROW TRANSPLANTATION, 2013, 48 (02) :183-185
[34]  
Ciurea S.O., 2018, BONE MARROW TRANSPLA
[35]   Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia [J].
Ciurea, Stefan O. ;
Zhang, Mei-Jie ;
Bacigalupo, Andrea A. ;
Bashey, Asad ;
Appelbaum, Frederick R. ;
Aljitawi, Omar S. ;
Armand, Philippe ;
Antin, Joseph H. ;
Chen, Junfang ;
Devine, Steven M. ;
Fowler, Daniel H. ;
Luznik, Leo ;
Nakamura, Ryotaro ;
O'Donnell, Paul V. ;
Perales, Miguel-Angel ;
Pingali, Sai Ravi ;
Porter, David L. ;
Riches, Marcie R. ;
Ringden, Olle T. H. ;
Rocha, Vanderson ;
Vij, Ravi ;
Weisdorf, Daniel J. ;
Champlin, Richard E. ;
Horowitz, Mary M. ;
Fuchs, Ephraim J. ;
Eapen, Mary .
BLOOD, 2015, 126 (08) :1033-1040
[36]   Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation [J].
Ciurea, Stefan O. ;
Thall, Peter F. ;
Milton, Denai R. ;
Barnes, Titus H. ;
Kongtim, Piyanuch ;
Carmazzi, Yudith ;
Lopez, Asdrubal A. ;
Yap, Dianne Y. ;
Popat, Uday ;
Rondon, Gabriela ;
Lichtiger, Benjamin ;
Aung, Fleur ;
Afshar-Kharghan, Vahid ;
Ma, Qing ;
Fernandez-Vina, Marcelo ;
Champlin, Richard E. ;
Cao, Kai .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (08) :1392-1398
[37]   Donor Selection in T Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies [J].
Ciurea, Stefan O. ;
Champlin, Richard E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) :180-184
[38]   High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem-Cell Transplantation [J].
Ciurea, Stefan O. ;
de Lima, Marcos ;
Cano, Pedro ;
Korbling, Martin ;
Giralt, Sergio ;
Shpall, Elizabeth J. ;
Wang, Xuemei ;
Thall, Peter F. ;
Champlin, Richard E. ;
Fernandez-Vina, Marcelo .
TRANSPLANTATION, 2009, 88 (08) :1019-1024
[39]   Nonmyeloablative Peripheral Blood Haploidentical Stem Cell Transplantation for Refractory Severe Aplastic Anemia [J].
Clay, Jennifer ;
Kulasekararaj, Austin G. ;
Potter, Victoria ;
Grimaldi, Francesco ;
McLornan, Donal ;
Raj, Kavita ;
de Lavallade, Hugues ;
Kenyon, Michelle ;
Pagliuca, Antonio ;
Mufti, Ghulam J. ;
Marsh, Judith C. W. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) :1711-1716
[40]   Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models [J].
Del Papa, Beatrice ;
Ruggeri, Loredana ;
Urbani, Elena ;
Baldoni, Stefano ;
Cecchini, Debora ;
Zei, Tiziana ;
Ostini, Roberta Iacucci ;
Crescenzi, Barbara ;
Carotti, Alessandra ;
Pierini, Antonio ;
Sportoletti, Paolo ;
Di Bartolomeo, Paolo ;
Falzetti, Franca ;
Mecucci, Cristina ;
Velardi, Andrea ;
Martelli, Massimo F. ;
Di Ianni, Mauro .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (11) :1847-1851